Neomycin Sulfate and Dexamethasone Sodium Phosphate Cream
» Neomycin Sulfate and Dexamethasone Sodium Phosphate Cream contains the equivalent of not less than 90.0 percent and not more than 135.0 percent of the labeled amount of neomycin, and the equivalent of not less than 90.0 percent and not more than 110.0 percent of the labeled amount of dexamethasone phosphate (C22H30FO8P).
Packaging and storage— Preserve in collapsible tubes or in tight containers.
Identification—
A: It meets the requirements for neomycin under Thin-Layer Chromatographic Identification Test 201BNP.
B: The Assay preparation, prepared as directed in the Assay for dexamethasone phosphate, meets the requirements for the Identification test under Dexamethasone Sodium Phosphate Cream.
Minimum fill 755: meets the requirements.
Assay for neomycin— Proceed with Cream as directed in the Assay under Neomycin Sulfate Cream.
Assay for dexamethasone phosphate—
Alcohol–aqueous phosphate buffer, 0.05 M Phosphate buffer, Mobile phase, Standard preparation, and Chromatographic system— Prepare as directed in the Assay under Dexamethasone Sodium Phosphate Cream.
Assay preparation— Using an accurately weighed portion of Cream, prepare as directed in the Assay under Dexamethasone Sodium Phosphate Cream.
Procedure— Proceed as directed for Procedure in the Assay under Dexamethasone Sodium Phosphate Cream. Calculate the quantity, in mg, of dexamethasone phosphate (C22H30FO8P) in the portion of Cream taken by the formula:
0.1C(rU / rS).
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Ahalya Wise, M.S.
Scientist
1-301-816-8161		 (MDANT05) Monograph Development-Antibiotics
Reference Standards Lili Wang, Technical Services Scientist
1-301-816-8129
RSTech@usp.org
USP32–NF27 Page 3048
Pharmacopeial Forum: Volume No. 28(4) Page 1154
Chromatographic Column—
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.